This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cao, Y. Articles by Lawrence, T. S. Search for Related Content PubMed PubMed Citation Articles by Cao, Y. Articles by Lawrence, T. S.

The Extent and Severity of Vascular Leakage as Evidence of Tumor Aggressiveness in High-Grade Gliomas

Departments of ¹ Radiation Oncology, ² Radiology, and ³ Neurology, University of Michigan, Ann Arbor, Michigan

Requests for reprints: Yue Cao, Department of Radiation Oncology, University of Michigan, 1500 East Medical Center Drive, B2C438, Box 0010, Ann Arbor, MI 48109-0010. Phone: 734-936-4309; Fax: 734-936-7859; E-mail: yuecao{at}med.umich.edu.

Magnetic resonance imaging reveals heterogeneous regions within high-grade gliomas, such as a contrast-enhanced rim, a necrotic core, and non–contrast-enhanced abnormalities. It is unclear which of these regions best describes tumor aggressiveness. We hypothesized that the vascular leakage volume, reflecting disorganized angiogenesis typical of glioblastoma, would be a strong predictor of clinical outcome. The FLAIR tumor volume, post-gadolinium T1 tumor volume, tumor vascular leakage volume determined by dynamic contrast-enhanced imaging, and volume of the contrast-enhanced rim seen on post-gadolinium T1-weighted images were defined for 20 patients about to undergo treatment for newly diagnosed high-grade gliomas. The potential for imaging characteristics to improve prediction of survival and time to progression over clinical variables was tested by using Cox regression analysis. Single-variable Cox regression analysis of each of the four tumor subvolumes revealed that the vascular leakage volume was the only significant predictor of survival. When the joint effect of clinical variables and the vascular leakage volume were tested for prediction of survival, only the age and the vascular leakage volume were selected as significant predictors. However, when time to progression was tested as a dependent variable, both the vascular leakage volume and the vascular permeability were selected as copredictors, along with surgical status. Our findings suggest that for patients with high-grade glioma, time to progression after radiation therapy is influenced by both underlying biological aggressiveness (vascularity) and volume of aggressive tumor. In contrast, survival depends chiefly on the volume of aggressive tumor at the time of presentation. (Cancer Res 2006; 66(17): 8912-7)

This article has been cited by other articles:

				K. R. Swanson, G. Chakraborty, C. H. Wang, R. Rockne, H. L.P. Harpold, M. Muzi, T. C.H. Adamsen, K. A. Krohn, and A. M. Spence Complementary but Distinct Roles for MRI and 18F-Fluoromisonidazole PET in the Assessment of Human Glioblastomas J. Nucl. Med., January 1, 2009; 50(1): 36 - 44. [Abstract] [Full Text] [PDF]

				J. Lazovic, M. C. Jensen, E. Ferkassian, B. Aguilar, A. Raubitschek, and R. E. Jacobs Imaging Immune Response In vivo: Cytolytic Action of Genetically Altered T Cells Directed to Glioblastoma Multiforme Clin. Cancer Res., June 15, 2008; 14(12): 3832 - 3839. [Abstract] [Full Text] [PDF]